[Drug interactions in therapy using coumarin derivatives].
D000493:Allopurinol / Q000378:metabolism; D000893:Anti-Inflammatory Agents / Q000378:metabolism; D001463:Barbiturates / Q000378:metabolism; D001682:Biological Availability; D002792:Cholestyramine Resin / Q000378:metabolism; D003374:Coumarins / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D008795:Metronidazole / Q000378:metabolism; D010653:Phenylbutazone / Q000378:metabolism; D012293:Rifampin / Q000378:metabolism; D013449:Sulfonamides / Q000378:metabolism; D014044:Tolbutamide / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D001463:Barbiturates; D003374:Coumarins; D013449:Sulfonamides; D002792:Cholestyramine Resin; D008795:Metronidazole; D000493:Allopurinol; D014044:Tolbutamide; D010653:Phenylbutazone; D012293:Rifampin
Arzneimittelwechselwirkungen in der Therapie mit Cumarin-Derivaten.